GlaxoSmithKline is eyeing another indication for its Nucala (mepolizumab) biologic drug after a phase 3 trial in inflammation caused by nasal polyps hit its targets, bringing it into competition ...

Both assets are poised to enter registrational studies under accelerated approval pathways, according to Jefferies. GSK to Stay Out of Obesity—but not GLP-1s At JPM25 on Monday, GSK Chief Scientific ...

GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from existing assets. At the JPMorgan Healthcare Conference, the European healthcare giant noted there ...

Preheat oven to 350 degrees. Line a 9-inch-by-13-inch or similar baking dish with foil and spray the bottom with cooking spray. Mix together the mayonnaise and ketchup and set aside. Pull rolls ...

Learn More Pharmaceutical giant GSK is pushing the boundaries of what generative AI can achieve in healthcare areas like scientific literature review, genomic analysis and drug discovery.

Eli Lilly made a $2.5 billion deal for a breast cancer drug; GSK reached a $1 billion-plus deal for IDRx. The announcements suggest a potential rebound in M&A deals in the healthcare sector for 2025.

The company also resolved accusations that it paid kickbacks to doctors to prescribe those drugs as well as the drugs Imitrex, Lotronex, Flovent and Valtrex. "GSK's sales force bribed physicians to ...

The deal includes an upfront payment of $1bn and an additional $150m tied to regulatory milestones. Credit: Bloomberg via Getty Images. GSK has announced a definitive agreement to acquire IDRx, a ...

Until now, sumatriptan administration takes place in tablet form, as a nasal spray or as an injection. Many migraine patients become nauseous or suffer from vomiting, which means that both tablets ...

There are few things more dispiriting than wearing a new pair of shoes on a bad weather day, then coming home and finding water stains or rings of road salt once they’ve dried. Although there ...

Ltd. The funds will support the inorganic expansion strategy of Neuberg, which says it is the fourth-largest diagnostic player in India. The company, which was founded by industry veteran GSK Velu, ...